1
Return

Ferroptosis-Mediated Inflammation Promotes Pulmonary Hypertension

delete2024-11-08
delete0
PRE
AI
F
Felipe Kazmirczak
N
Neal Vogel
S
Sasha Z. Prisco
M
Michael T. Patterson
J
Jeffrey Annis
R
Ryan Moon
L
Lynn M. Hartweck
J
Jenna B. Mendelson
M
Minwoo Kim
N
Natalia Calixto Mancipe
T
Todd W. Markowski
L
LeeAnn Higgins
C
Candace Guerrero
K
Kremer, Ben
M
Madelyn Blake
C
Christopher J. Rhodes
J
Jesse W. Williams
E
Evan L. Brittain
K
Kurt W. Prins *
DOI:10.1161/CIRCRESAHA.123.324138delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
BACKGROUND:Mitochondrial dysfunction, characterized by impaired lipid metabolism and heightened reactive oxygen species generation, results in lipid peroxidation and ferroptosis. Ferroptosis is an inflammatory mode of cell death that promotes complement activation and macrophage recruitment. In pulmonary arterial hypertension (PAH), pulmonary arterial endothelial cells exhibit cellular phenotypes that promote ferroptosis. Moreover, there is ectopic complement deposition and inflammatory macrophage accumulation in the pulmonary vasculature. However, the effects of ferroptosis inhibition on these pathogenic mechanisms and the cellular landscape of the pulmonary vasculature are incompletely defined.METHODS:Multiomics and physiological analyses evaluated how ferroptosis inhibition-modulated preclinical PAH. The impact of adeno-associated virus 1-mediated expression of the proferroptotic protein ACSL (acyl-CoA synthetase long-chain family member) 4 on PAH was determined, and a genetic association study in humans further probed the relationship between ferroptosis and pulmonary hypertension.RESULTS:Ferrostatin-1, a small-molecule ferroptosis inhibitor, mitigated PAH severity in monocrotaline rats. RNA-sequencing and proteomics analyses demonstrated ferroptosis was associated with PAH severity. RNA-sequencing, proteomics, and confocal microscopy revealed complement activation and proinflammatory cytokines/chemokines were suppressed by ferrostatin-1. In addition, ferrostatin-1 combatted changes in endothelial, smooth muscle, and interstitial macrophage abundance and gene activation patterns as revealed by deconvolution RNA-sequencing. Ferroptotic pulmonary arterial endothelial cell damage-associated molecular patterns restructured the transcriptomic signature and mitochondrial morphology, promoted the proliferation of pulmonary artery smooth muscle cells, and created a proinflammatory phenotype in monocytes in vitro. Adeno-associated virus 1-Acsl4 induced an inflammatory PAH phenotype in rats. Finally, single-nucleotide polymorphisms in 6 ferroptosis genes identified a potential link between ferroptosis and pulmonary hypertension severity in the Vanderbilt BioVU repository.CONCLUSIONS:Ferroptosis promotes PAH through metabolic and inflammatory mechanisms in the pulmonary vasculature.
Keywords:
cardiovascular diseases
ferroptosis
hypertension, pulmonary
mitochondria

Journal

Circulation Research cover
Circulation Research
IF:
16.2
Papers:
1.3W
Citations:
6.4W

Organization

U
University of Minnesota Twin Cities
Scholars:
3.7W
Papers: 3.1W
Citations: 58
M
Minneapolis Heart Institute Foundation
Scholars:
1.4K
Papers: 1.0K
Citations: 863
Cited Papers

Cited Papers

Citing Papers

Citing Papers